Revolution Medicines Inc (NAS:RVMDW)
$ 0.5382 -0.0718 (-11.77%) Market Cap: - Enterprise Value: - PE Ratio: 9,999.00 PB Ratio: 0 GF Score: 41/100

Q4 2022 Revolution Medicines Inc Earnings Call Transcript

Feb 27, 2023 / 09:30PM GMT
Operator

Good day and thank you for standing by. Welcome to the Revolution Medicines Q4 Year-end 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Peg Horn, Chief Operating Officer. Please go ahead.

Margaret A. Horn
Revolution Medicines, Inc. - COO

Thank you and welcome, everyone, to the fourth quarter and full year 2022 earnings call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicines' Chairman and Chief Executive Officer; Dr. Steve Kelsey, the company's President of Research and Development; and Jack Anders, our Chief Financial Officer.

As we begin, I would like to note that our presentation will include statements regarding the current beliefs of the company with respect to our business that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These statements are subject to a number of assumptions, risks and uncertainties. Actual results may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot